ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	33/326	73/5959	4.07043960572762e-23	1.55897836899368e-20	1.30254067383284e-20	6356/6362/6347/6364/6368/6348/6351/9560/6355/1437/1440/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3589/3605/3552/3553/3557/11009/3569/4312/4314/5008/5196/6696	33
WP5055	Burn wound healing	30/326	93/5959	3.61515710268258e-16	6.92302585163713e-14	5.78425136429212e-14	8038/6347/57124/1277/1278/2919/3579/10468/3082/3383/3552/3553/3569/3624/3853/4312/4322/4313/4314/64332/64127/6280/8796/6423/7042/7043/7076/7097/51311/3371	30
WP5115	Network map of SARS-CoV-2 signaling pathway	36/326	190/5959	2.36358577409336e-11	3.01751117159252e-09	2.52115815903291e-09	6356/6347/6364/6348/6351/6355/1051/3426/1294/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/2247/10410/3458/3605/3552/3553/3569/3699/5196/5743/6288/6289/6403/5104/5054/6772/7018	36
WP3624	Lung fibrosis	18/326	52/5959	9.43606367752742e-11	9.0350309712325e-09	7.54885094202193e-09	6356/6347/6348/6351/1051/1437/1440/2920/2247/2252/26585/3082/3553/3569/4313/5328/6696/7076	18
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	18/326	63/5959	3.28957467411005e-09	2.5198142003683e-07	2.10532779143043e-07	6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3569/5196/6772/7020	18
WP2431	Spinal cord injury	22/326	98/5959	8.44229778085383e-09	5.38900008344503e-07	4.50255881645537e-07	63827/6347/1280/1282/2919/3627/2920/2212/2697/3383/3458/3552/3553/3569/10288/11025/4321/4843/5743/6403/6869/1462	22
WP2806	Complement system	19/326	75/5959	1.0856259211811e-08	5.93992468303372e-07	4.96286135397073e-07	722/728/27202/729/1604/22918/3426/10332/1380/2214/2219/2357/2769/3383/5648/6401/6403/6696/7097	19
WP4462	Platelet-mediated interactions with vascular and circulating cells	9/326	17/5959	6.48529684617582e-08	3.10483586510667e-06	2.59411873847033e-06	6347/3383/3553/5196/6401/6403/7042/7043/7097	9
WP5088	Prostaglandin signaling	11/326	28/5959	1.03178370853926e-07	4.15022636214108e-06	3.46755205191944e-06	6347/6348/2919/3627/4283/3458/3605/3552/3553/3569/9536	11
WP2848	Pluripotent stem cell differentiation pathway	12/326	34/5959	1.08361001622482e-07	4.15022636214108e-06	3.46755205191944e-06	3577/2255/2247/10468/3082/3589/3569/3624/7018/7043/7472/7474	12
WP24	Peptide GPCRs	13/326	41/5959	1.35715250131414e-07	4.72535825457561e-06	3.94808000382296e-06	728/1230/1237/3577/3579/1909/2357/2358/4886/4887/5540/6869/7253	13
WP530	Cytokines and inflammatory response	9/326	19/5959	2.23445676331425e-07	7.13164116957798e-06	5.958551368838e-06	1437/1440/2919/2920/3458/3589/3552/3553/3569	9
WP4754	IL-18 signaling pathway	33/326	239/5959	5.72596010377813e-07	1.68695593826694e-05	1.40946710246846e-05	6362/6347/6364/6348/6351/1051/9076/1277/1278/1281/2920/2921/338442/3383/3458/3553/3559/3569/4312/4322/4313/4314/4688/64332/4843/7941/5743/9021/6696/6869/7018/7076/79931	33
WP3617	Photodynamic therapy-induced NF-kB survival signaling	11/326	33/5959	7.25860979660954e-07	1.98574825150104e-05	1.65911081065361e-05	1437/2920/3383/3552/3553/3569/4312/4313/4314/5743/6401	11
WP2911	miRNA targets in ECM and membrane receptors	9/326	22/5959	1.03891385590102e-06	2.65269337873393e-05	2.21634955925551e-05	1278/1281/1282/1284/1289/1290/50509/1293/7058	9
WP4891	COVID-19 adverse outcome pathway	7/326	13/5959	1.7751767914766e-06	4.24932944459712e-05	3.5503535829532e-05	6347/6348/1440/3627/3553/3559/3569	7
WP129	Matrix metalloproteinases	9/326	24/5959	2.47654284049823e-06	5.57950534065189e-05	4.66172769976137e-05	4312/4319/4321/4322/4327/4313/4314/4316/7076	9
WP455	GPCRs, class A rhodopsin-like	20/326	118/5959	4.81752837468018e-06	0.000102506298194584	8.56449488832032e-05	27202/1230/1237/3577/3579/1909/2151/2867/2357/2358/2828/8843/3274/64106/4886/4887/5540/5724/5739/56670	20
WP558	Complement and coagulation cascades	12/326	48/5959	6.86536142723341e-06	0.000138391232980547	0.000115627139827089	728/729/1604/3426/1380/2153/5648/5328/5104/5054/7056/7450	12
WP2865	IL1 and megakaryocytes in obesity	8/326	23/5959	1.75142051157519e-05	0.000335397027966648	0.00028022728185203	6347/3383/3458/3553/7941/6280/7076/7097	8
WP1533	Vitamin B12 metabolism	10/326	37/5959	1.93694234446376e-05	0.000353261389490296	0.000295153119156383	6347/3383/3458/3553/3569/6288/6289/5054/6648/6947	10
WP4494	Selective expression of chemokine receptors during T-cell polarization	8/326	24/5959	2.50330362533786e-05	0.000435802403865636	0.000364116890958234	6348/6351/1230/1437/3458/3595/7042/7043	8
WP474	Endochondral ossification	12/326	57/5959	4.46161696075175e-05	0.000711999706653301	0.000594882261433567	9510/9507/249/1280/2247/4256/4322/5328/5744/6696/6772/7042	12
WP4808	Endochondral ossification with skeletal dysplasias	12/326	57/5959	4.46161696075175e-05	0.000711999706653301	0.000594882261433567	9510/9507/249/1280/2247/4256/4322/5328/5744/6696/6772/7042	12
WP619	Type II interferon signaling (IFNG)	9/326	34/5959	6.1017937480199e-05	0.000934794802196649	0.000781029599746548	3627/4283/2633/3383/3458/3553/4843/9021/6772	9
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	30/326	265/5959	9.9594948782957e-05	0.00146711020707202	0.00122578398502101	285/1277/1278/1280/1281/1282/1284/1289/1290/50509/9586/1440/1441/2255/2247/2252/3082/3559/3678/10319/4843/5008/9180/5209/5228/6515/6696/7058/3371/7450	30
WP5090	Complement system in neuronal development and plasticity	15/326	93/5959	0.000135116665109318	0.00191665491618032	0.00160138269759192	722/725/728/27202/729/1604/3426/10584/1380/2219/8547/3458/5648/7042/7043	15
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	12/326	65/5959	0.00017106396734932	0.00233991069624249	0.00195501676970652	2354/8456/94234/10468/2619/3458/3488/5653/5650/22822/11005/7474	12
WP3967	miR-509-3p alteration of YAP1/ECM axis	6/326	17/5959	0.000189463283040268	0.00250222197946285	0.00209062933009951	1277/1281/1289/1909/7058/7291	6
WP2328	Allograft Rejection	13/326	76/5959	0.000206135564110445	0.00263166403514335	0.00219877935051142	729/1604/1289/6373/4283/50943/3002/3458/3605/3552/3553/3559/6772	13
WP615	Senescence and autophagy in cancer	15/326	97/5959	0.000219256751908395	0.00270888180583598	0.00226329550357053	6348/1051/1277/1281/2919/3458/3488/3552/3553/11009/3569/3624/5328/5054/29986	15
WP2877	Vitamin D receptor pathway	19/326	142/5959	0.000237219591180761	0.00283922198194474	0.00237219591180761	768/1543/1594/168002/1673/50486/3488/9173/5653/5744/6273/6279/6280/219855/6696/79689/7042/7056/54210	19
WP5092	Interactions of natural killer cells in pancreatic cancer	7/326	25/5959	0.000280719778965096	0.00325805076798884	0.00272213118996456	6347/6348/6351/1437/2214/3002/3458	7
WP15	Selenium micronutrient network	11/326	59/5959	0.000291188424041165	0.0032801519531696	0.00274059693215214	6347/3383/3458/3553/3569/8942/5743/6288/6289/5054/6648	11
WP465	Tryptophan metabolism	8/326	33/5959	0.00030641869335175	0.00335309598724915	0.002801542339216	8854/316/1543/1545/9420/3620/8942/6999	8
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	7/326	28/5959	0.000599845101059269	0.00638168538071389	0.00533195645386017	6347/29126/3627/3559/7042/7043/51311	7
WP176	Folate metabolism	9/326	48/5959	0.000989981285390083	0.0100030584946499	0.0083576467840417	6347/3383/3458/3553/3569/6288/6289/5054/6648	9
WP4329	miRNAs involvement in the immune response in sepsis	8/326	39/5959	0.00101858820180508	0.0100030584946499	0.0083576467840417	6348/6351/3002/3383/3552/3569/3934/51311	8
WP5097	CCL18 signaling pathway	8/326	39/5959	0.00101858820180508	0.0100030584946499	0.0083576467840417	1237/1278/1437/4313/6615/6772/7020/7291	8
WP4478	LTF danger signal response pathway	5/326	16/5959	0.00125789163922554	0.0117074007759347	0.00978164033498459	3552/3553/3569/7097/54210	5
WP4493	Cells and molecules involved in local acute inflammatory response 	5/326	16/5959	0.00125789163922554	0.0117074007759347	0.00978164033498459	729/3383/3552/3569/6403	5
WP4172	PI3K-Akt signaling pathway	28/326	280/5959	0.00128384029396673	0.0117074007759347	0.00978164033498459	285/1277/1278/1280/1282/1284/1293/131873/9586/1440/1441/2255/2247/2252/3082/3559/3569/3678/10319/4915/5008/9180/5228/6696/7058/7097/3371/7450	28
WP2374	Oncostatin M signaling pathway	10/326	64/5959	0.00225579673842221	0.0200923290887373	0.0167873245650025	6347/1051/4312/4322/4314/5008/9180/5054/9021/6772	10
WP4239	Epithelial to mesenchymal transition in colorectal cancer	16/326	134/5959	0.00248007576012865	0.0215879321847562	0.0180369146191175	9076/51208/9073/1282/1284/94234/11211/3678/4313/4854/6615/7042/7043/7291/7472/7474	16
WP5087	Malignant pleural mesothelioma	32/326	350/5959	0.00259029063343353	0.0220462513912231	0.0184198445044162	285/6347/6351/29126/1001/1282/1284/1437/1440/2919/3627/6374/2255/2247/2252/8061/11211/3082/3620/3553/3569/10319/4313/4314/4915/5228/5328/6423/8140/6772/7472/7474	32
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	6/326	27/5959	0.0028473176460301	0.0237070143136854	0.0198074271028181	6347/3553/3569/4312/4314/23657	6
WP2882	Nuclear receptors meta-pathway	26/326	268/5959	0.00291243504039262	0.0237259535434245	0.019823251002339	8647/874/6347/6364/1543/1545/3082/3458/3589/3553/55554/3084/5142/5743/154091/6515/29986/160728/11254/23657/8140/5552/27286/7042/7056/84951	26
WP5094	Orexin receptor pathway	14/326	112/5959	0.00297348765035085	0.0237259535434245	0.019823251002339	2920/1846/2354/3383/3553/3569/4023/4322/4314/64106/8013/6401/6696/3371	14
